J. DONALD PAYNE JOINS LIFECELL AS VICE PRESIDENT, CHIEF FINANCIAL OFFICER AND SECRETARY.THE WOODLANDS, Texas--(BUSINESS WIRE)--March 20, 1997--LifeCell Corporation (Nasdaq:LIFC) today announced that J. Donald Payne has joined the Company as Vice President, Chief Financial Officer and Secretary. Mr. Payne will be responsible for LifeCell's financial and accounting activities, preparation of Securities and Exchange Commission filings, general administration and investor relations. Prior to joining LifeCell, Mr. Payne was most recently Vice President, Finance, Chief Financial Officer and Director of Aprogenex, Inc. From 1980 to 1990, Mr. Payne was Vice President, Finance, Corporate Treasurer, Corporate Secretary and Chief Financial Officer of UMC UMC United Methodist Church UMC United Microelectronics Corporation UMC University Medical Center UMC United Microelectronics Corp (Republic of China) UMC University of Missouri-Columbia Petroleum Corporation. He has additional experience as a senior auditor with Arthur Andersen and Co. and as an independent financial consultant in oil and gas property acquisition. Mr. Payne received his Bachelor of Business Administration “BBA” redirects here. For other uses, see BBA (disambiguation). The Bachelor of Business Administration (BBA) is a bachelor's degree in business studies. in Accounting from Texas A&M University, a Masters of Business Administration from Rice University and is a Certified Public Accountant Certified Public Accountant (CPA) An accountant who has met certain standards, including experience, age, and licensing, and passed exams in a particular state. . "We are extremely pleased to add Don Payne to our management team," said Paul M. Frison, president and chief executive officer of LifeCell Corporation. "His extensive experience in finance, business development, licensing and investor relations will be a great asset to the Company as we advance the sales, marketing and distribution of our AlloDerm product line and the commercial development of our multiple product pipeline." LifeCell Corporation develops and commercializes universal tissue grafts and blood cell preservation products. LifeCell's first commercial product, AlloDerm preserved human dermis dermis: see skin. , is used in plastic and reconstructive surgery, in periodontal surgery, and in the treatment of third-degree burns. In addition to AlloDerm grafts, the Company's current universal tissue graft development programs include XenoDerm porcine porcine /por·cine/ (por´sin) pertaining to swine. porcine pertaining to pig. See also hog (1), swine. porcine circovirus 1 a nonpathogenic virus. dermal graft, the LifeCell heart valve (under an exclusive license agreement with Medtronic, Inc. - (NYSE NYSE See: New York Stock Exchange :MDT MDT abbr. Mountain Daylight Time MDT (in the US and Canada) Mountain Daylight Time MDT n abbr (US) (= mountain daylight time) → ), and universal vascular conduits. LifeCell's product development programs also include ThromboSol, a formulation for extending the shelf-life of transfusable platelets. For additional information about the Company, visit LifeCell's web site: http://www.lifecell.com CONTACT: LifeCell Corp., The Woodlands Jane Lea Hicks, 713/367-5368 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion